Optimal schedule for anthracyclines
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference15 articles.
1. Pharmacokinetics and metabolism of adriamycin in man;Benjamin;Clin Pharmacol Ther,1973
2. Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model;Chan;Cancer Treat Rep,1978
3. Phase II evaluation of adriamycin in human neoplasia;O'Bryan;Cancer,1973
4. Adriamycin chemotherapy—efficacy, safety and pharmacologic basis of an intermittent single high-dosage schedule;Benjamin;Cancer,1974
5. An effective low-dose adriamycin regimen as secondary chemotherapy for metastatic breast cancer patients;Creech;Cancer,1980
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New aspects in probucol cardioprotection against doxorubicin-induced cardiotoxicity;Cancer Chemotherapy and Pharmacology;2003-11-01
2. Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: a prospective randomised study;European Journal of Cancer;2002-11
3. Aspects pédiatriques de la toxicité cardiaque des anthracyclines et implications pratiques pour sa prévention;Archives de Pédiatrie;1995-10
4. Doxorubicin weekly low dose administration: in vitro cytotoxicity generated by the typical pharmacokinetic profile;European Journal of Cancer;1992-01
5. Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A southwest oncology group study;Cancer;1991-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3